Heuking Kühn Lüer Wojtek advises shareholders of medtech company Acti-Med AG on sale to Gilde Healthcare

A team led by private equity lawyer Dr. Andreas Lenz, Partner at the Cologne office, advised the shareholders of medtech company Acti-Med AG on the sale of all shares to an acquisition vehicle of private equity investor Gilde Healthcare.
Acti-Med AG was founded in 1997 and is headquartered in Freiensteinau. Acti-Med manufactures and develops tailor-made cannulas and cannula systems for pharmaceutical and medical applications, jointly developed with international OEMs and is one of the world’s leading suppliers in this field. Acti-Med operates a wholly owned subsidiary in Kozerkí (Poland).
Gilde Healthcare is a leading international investor in healthcare and pharmaceuticals, managing over EUR 1.4 billion across two fund strategies, Private Equity and Venture & Growth Capital. The Private Equity fund invests in profitable European lower mid-market healthcare companies with a prime focus on the Benelux and DACH regions. It targets healthcare providers, suppliers of medical products, and service providers in the healthcare market. The Venture & Growth Capital fund invests in medtech, healthtech, and therapeutics.
The sale was part of a structured sales process.

Counsel to Acti-Med AG
Heuking Kühn Lüer Wojtek: 

Dr. Andreas Lenz (Lead, M&A),
Bastian Rieck, 
Dr. Vera Randel,
Dr. Christoph Schork, LL.M. (all Corporate/M&A),
Kerstin Deiters, LL.M., EMBA (Employment, Pensions),
Dr. Verena Hoene, LL.M. (University of Washington),
Kai Oliver Runkel (both IT, Data Protection, IP), all Cologne
Christoph Wagner (Berlin, Medicinal Products; Corporate), Berlin
Counsel in Polish law
bnt Neupert Zamorska & Partnerzy Sp.J., Warsaw:

Dominika Wagrodzka (Lead Poland, Corporate/M&A),
Kamil Kucharski (Corporate, Commercial),
Katarzyna Harna (Employment, Pensions)

Download as PDF

Contact persons

You are currently using an outdated and no longer supported browser (Internet Explorer). To ensure the best user experience and save you from possible problems, we recommend that you use a more modern browser.